Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
No of Months
12
12
12
12
Operating Income
631.00
505.00
349.00
247.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
631.00
505.00
349.00
247.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
Employee Cost
0.00
34.00
0.00
0.00
Operating Expenses
6.00
7.00
8.00
28.00
General and Administration Expenses
238.00
201.00
119.00
66.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
423.00
361.00
217.00
153.00
Operating Profit (PBDIT) excl Other Income
208.00
144.00
132.00
93.00
Other Income
18.00
14.00
14.00
8.00
Operating Profit (PBDIT)
235.00
163.00
150.00
105.00
Interest
6.00
7.00
8.00
28.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
Depreciation
8.00
5.00
4.00
3.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
214.00
161.00
146.00
85.00
Provision for Tax
22.00
14.00
16.00
5.00
Profit After Tax
191.00
147.00
129.00
80.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
2.76
2.20
1.93
1.25
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 24.82% vs 44.62% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 44.72% vs 9.02% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -20.54% vs -8.55% in Dec 2024
Profit After Tax
YoY Growth in year ended Dec 2025 is 30.13% vs 13.68% in Dec 2024
Compare Profit and Loss Results of Fujian Haixi New Drug Creation Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(HKD)
Change(%)
No of Months
12
12
Operating Income
631.00
0
631.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
631.00
0
631.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
6.00
0
6.00
0%
General and Administration Expenses
238.00
0
238.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
423.00
0
423.00
0%
Operating Profit (PBDIT) excl Other Income
208.00
0.00
208.00
0%
Other Income
18.00
0
18.00
0%
Operating Profit (PBDIT)
235.00
0
235.00
0%
Interest
6.00
0
6.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
8.00
0
8.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
214.00
0
214.00
0%
Provision for Tax
22.00
0
22.00
0%
Profit After Tax
191.00
0
191.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.7622
0
2.76
0%
Profit And Loss - Net Sales
Net Sales 631.58 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 24.82% vs 44.62% in Dec 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 208.52 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 44.72% vs 9.02% in Dec 2024
Profit And Loss - Interest
Interest 6.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -20.54% vs -8.55% in Dec 2024
Profit And Loss - Profit After Tax
Profit After Tax 191.99 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 30.13% vs 13.68% in Dec 2024






